Lupin Limited

Lupin Limited is an innovation-led transnational pharmaceutical company that has established its presence in over 100 countries, recording a turnover of US $2.5 billion. Specialising in the development of difficult-to-develop, specialty, and niche generics in various therapeutic areas, including CNS, anti-infectives, respiratory, cardiovascular, urology, pain, and diabetes, Lupin is committed to advancing healthcare through its comprehensive portfolio. With ongoing investments directed towards internalising technology platforms in biotechnology, complex and long-acting injectables, and inhalation, the company is poised to emerge as a global pharmaceutical powerhouse.

Services include:
- Small Molecule, Drug Substance Manufacturing (API)
- Contract Development and Manufacturing Organisation (CDMO) services
- Inhalation products
- Custom pharmaceutical development
- Product development and formulation services

Lupin Limited continues to strengthen its position in the pharmaceutical industry by delivering high-quality solutions tailored to meet the specific needs of its clients. For further details, visit lupin.com.